Search research articles
Contact Us
Filters
Showing results (61-70 of 113) with videos related to
Page
of 12
Sort By:
The New England Journal of Medicine
|
February 16, 1984
Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979
I Turesson, O Zettervall, J Cuzick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 1, 1984
The influence of irradiation time per treatment session on acute and late skin reactions: a study on human skin
I Turesson, G Notter, I Wickström, et al.
Clinical Implant Dentistry and Related Research
|
May 19, 2001
A histomorphometric and biomechanical study of the effect of delayed titanium implant placement in irradiated rabbit bone
A A Johnsson, T Sawaii, M Jacobsson, et al.
The International Journal of Oral & Maxillofacial Implants
|
October 26, 1999
A histomorphometric study of bone reactions to titanium implants in irradiated bone and the effect of hyperbaric oxygen treatment
A A Johnsson, T Sawaii, M Jacobsson, et al.
International Journal of Oncology
|
June 11, 2009
gammaH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids
O F Qvarnström, M Simonsson, V Eriksson, et al.
European Journal of Haematology
|
June 8, 1999
Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios
K Carlson, A Larsson, B Simonsson, et al.
Blood
|
February 3, 1998
Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group
C Seidel, M Børset, I Turesson, et al.
European Journal of Haematology
|
May 5, 1999
Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG)
M Hjorth, E Holmberg, S Rödjer, et al.
British Journal of Haematology
|
June 10, 2000
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma
G Juliusson, F Celsing, I Turesson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2001
Low-dose hypersensitivity: current status and possible mechanisms
M C Joiner, B Marples, P Lambin, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 113) with videos related to
Sort By:
Page
of 12
The New England Journal of Medicine
|
February 16, 1984
Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979
I Turesson, O Zettervall, J Cuzick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 1, 1984
The influence of irradiation time per treatment session on acute and late skin reactions: a study on human skin
I Turesson, G Notter, I Wickström, et al.
Clinical Implant Dentistry and Related Research
|
May 19, 2001
A histomorphometric and biomechanical study of the effect of delayed titanium implant placement in irradiated rabbit bone
A A Johnsson, T Sawaii, M Jacobsson, et al.
The International Journal of Oral & Maxillofacial Implants
|
October 26, 1999
A histomorphometric study of bone reactions to titanium implants in irradiated bone and the effect of hyperbaric oxygen treatment
A A Johnsson, T Sawaii, M Jacobsson, et al.
International Journal of Oncology
|
June 11, 2009
gammaH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids
O F Qvarnström, M Simonsson, V Eriksson, et al.
European Journal of Haematology
|
June 8, 1999
Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios
K Carlson, A Larsson, B Simonsson, et al.
Blood
|
February 3, 1998
Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group
C Seidel, M Børset, I Turesson, et al.
European Journal of Haematology
|
May 5, 1999
Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG)
M Hjorth, E Holmberg, S Rödjer, et al.
British Journal of Haematology
|
June 10, 2000
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma
G Juliusson, F Celsing, I Turesson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2001
Low-dose hypersensitivity: current status and possible mechanisms
M C Joiner, B Marples, P Lambin, et al.
Page
of 12